122 related articles for article (PubMed ID: 38287713)
21. A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in China.
Wu P; Zhang Z; Yuan Y; Zhang C; Zhang G; Xue L; Yang H; Wang L; Zheng X; Zhang Y; Yuan Y; Lei R; Yang Z; Zheng B; Xue Q; Sun N; He J
Int J Surg; 2022 Nov; 107():106960. PubMed ID: 36257585
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
23. A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures.
Guo J; Tong C; Shi J; Li X; Chen X
Oncol Res; 2023; 32(1):199-212. PubMed ID: 38196829
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analyses Reveal Effects on Tumor Immune Infiltration and Immunotherapy Response of APOBEC Mutagenesis and Its Molecular Mechanisms in Esophageal Squamous Cell Carcinoma.
Yang J; Xiang T; Zhu S; Lao Y; Wang Y; Liu T; Li K; Ma Y; Zhong C; Zhang S; Tan W; Lin D; Wu C
Int J Biol Sci; 2023; 19(8):2551-2571. PubMed ID: 37215984
[TBL] [Abstract][Full Text] [Related]
25. Prognostic stratification of sepsis through DNA damage response based RiskScore system: insights from single-cell RNA-sequencing and transcriptomic profiling.
Lin Q; Zeng R; Yang J; Xu Z; Jin S; Wei G
Front Immunol; 2024; 15():1345321. PubMed ID: 38404591
[TBL] [Abstract][Full Text] [Related]
26. Mutational landscape of DNA damage response deficiency-related genes and its association with immune biomarkers in esophageal squamous cell carcinoma.
Chen G; Zhu YJ; Chen J; Miao F; Wu N; Song Y; Mao BB; Wang SZ; Xu F; Chen ZM
Neoplasma; 2022 Dec; 69(6):1314-1321. PubMed ID: 36264776
[TBL] [Abstract][Full Text] [Related]
27. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
Front Immunol; 2021; 12():676922. PubMed ID: 34335575
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma.
Li Y; Xu F; Chen F; Chen Y; Ge D; Zhang S; Lu C
EBioMedicine; 2021 Aug; 70():103510. PubMed ID: 34365093
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration.
Liu W; Yang HS; Zheng SY; Luo HH; Feng YF; Lei YY
BMC Bioinformatics; 2022 Sep; 23(1):406. PubMed ID: 36180848
[TBL] [Abstract][Full Text] [Related]
30. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
Ma C; Luo H
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781
[TBL] [Abstract][Full Text] [Related]
31. Identification of m
Ma Y; Sun Y; Zhao X; Li J; Fu X; Gong T; Zhang X
Sci Rep; 2023 Sep; 13(1):14499. PubMed ID: 37666951
[TBL] [Abstract][Full Text] [Related]
32. Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis.
Zhang P; Dong S; Sun W; Zhong W; Xiong J; Gong X; Li J; Lin H; Zhuang Y
Front Mol Biosci; 2023; 10():1277530. PubMed ID: 37842637
[No Abstract] [Full Text] [Related]
33. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
34. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
35. PES1 reduces CD8
Ma N; Hua R; Yang Y; Liu ZC; Pan J; Yu BY; Sun YF; Xie D; Wang Y; Li ZG
J Biomed Sci; 2023 Mar; 30(1):20. PubMed ID: 36959575
[TBL] [Abstract][Full Text] [Related]
36. Single-cell mapping of N6-methyladenosine in esophageal squamous cell carcinoma and exploration of the risk model for immune infiltration.
Nie Y; Yao G; Xu X; Liu Y; Yin K; Lai J; Li Q; Zhou F; Yang Z
Front Endocrinol (Lausanne); 2023; 14():1155009. PubMed ID: 37025404
[TBL] [Abstract][Full Text] [Related]
37. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma.
Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S
BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971
[TBL] [Abstract][Full Text] [Related]
38. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma.
Hong W; Zhang Y; Wang S; Zheng D; Hsu S; Zhou J; Fan J; Zeng Z; Wang N; Ding Z; Yu M; Gao Q; Du S
Cancer Lett; 2024 Feb; 582():216594. PubMed ID: 38135208
[TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of Co-Expressed Immune-Related Gene Signature Affecting the Pattern of Immune Infiltrating in Esophageal Cancer.
Cheng R; Zeng H; Chen L; Zhou L; Dong B
Comb Chem High Throughput Screen; 2023; 26(4):756-768. PubMed ID: 35959623
[TBL] [Abstract][Full Text] [Related]
40. Spatial heterogeneity and Immune infiltration of cellular lysosomal pathways reveals a new blueprint for tumor heterogeneity in esophageal cancer.
Wei J; Wu X; Wang S; Liu S; Gao X
Front Endocrinol (Lausanne); 2023; 14():1138457. PubMed ID: 37091857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
